Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...

A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing agreement to access Adaptive’s proprietary TCR-antigen datasets for research ...

A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range of infections at once.

clonoSEQ is the only DLBCL MRD assay available for clinical use and covered by Medicare SEATTLE, March 11, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial ...

A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range of infections at once. Traditionally, vaccines protect against one ...

Sat, January 24, 2026 at 2:56 PM UTC The immune system is the body’s natural defense network that helps to keep you healthy from things like bacteria, viruses, and parasites. It’s a complex network of ...

Sepsis remains a major challenge in modern medicine, claiming millions of lives each year. For decades, clinical management ...

Cancer immunotherapies, including cancer vaccines, harness and amplify the immune system’s natural ability to detect and attack cancer cells. In this illustration, immune T cells (pink) attach to a ...

The MarketWatch News Department was not involved in the creation of this content. A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data ...